Chuppa Rustom – PET and Dementias

Embed Size (px)

Citation preview

  • 8/2/2019 Chuppa Rustom PET and Dementias

    1/18

    Chuppa Rustom PET and

    Dementias

    Dr. Shemin Mehta

    3rd year DNB RadiologyDr. Balabhai Nanavati Hospital

  • 8/2/2019 Chuppa Rustom PET and Dementias

    2/18

    Dementia The Indian Perspective

    In 2010, there are 3.7 million Indians withdementia and the total societal cost isabout 14,700 crore

    The cost of taking care of a person withdementia is about Rs. 43,000/- annually

    While the numbers are expected to double

    by 2030, costs would increase three times Early detection allows early initiation of

    therapy to slow decline

  • 8/2/2019 Chuppa Rustom PET and Dementias

    3/18

    Diagnosis

    Dementia diagnosis is essentially clinical falsenegative in 50-90%

    Laboratory investigations play a supportive role

    Structural imaging in the form of CT and MRI isinadequate in early stages, as well as havinglow sensitivity and specificity

    Functional imaging, i.e. PET is more sensitiveand allows further disease characterization

  • 8/2/2019 Chuppa Rustom PET and Dementias

    4/18

    When to conduct a dementiaevaluation

    Patient/family concerns

    Functional impairment (driving, self-care)

    Changes in personality & behaviour

    Persistent cognitive deficit after deliriumclears

    Abrupt change in cognitive, emotional or

    neurologic status Depression associated with reversible

    dementia (50% irreversible after 5 years)

  • 8/2/2019 Chuppa Rustom PET and Dementias

    5/18

    Patterns

    Alzheimers Disease posterior cingulate,parietal and temporal cortices frontalinvolvement as AD progresses

    Frontotemporal Dementia frontotemporal

    abnormality with preserved posteriorfunctioning D/D from AD

    Vascular Dementia patchy hypometabolicpattern in cortical & subcorticalregions

    Dementia with Lewy Bodies parietal, temporaldeficits with frontal involvement as diseaseprogresses (similar to AD) along with occipitalhypometabolism

  • 8/2/2019 Chuppa Rustom PET and Dementias

    6/18

    Case 1

    70/M

    C/o forgetfulness,decreasedcomprehension, lack of

    responsiveness

    Insidious onset ofsymptoms

    CT - Moderate cerebralatrophy, prominence ofsylvian fissures

  • 8/2/2019 Chuppa Rustom PET and Dementias

    7/18

    MRI and MRS

    Multiple bilaterallacunar infarcts

    Mild cerebral and

    cerebellar atrophy Periventricular white

    matter ischemia

    MRS reduced NAA,mI and Chometabolic disorder

  • 8/2/2019 Chuppa Rustom PET and Dementias

    8/18

    PET-CT findings, Evaluation withScenium

    Hypometabolismbilateral temporo-parietal, frontal

    regions, bothhippocampi,amygdala, mesialtemporal lobe

    Occipital regionslargely unaffected

    Alzheimers disease

  • 8/2/2019 Chuppa Rustom PET and Dementias

    9/18

    Case 2

    77/M

    H/o socialdisinhibition,

    aggressiveness CT moderate

    atrophic changes,mild periventricularischemia

  • 8/2/2019 Chuppa Rustom PET and Dementias

    10/18

    PET-CT findings, Evaluation withScenium

    Frontotemporal deficit

    Preserved posteriorfunctioning

    Frontotemporaldementia (FTD)

  • 8/2/2019 Chuppa Rustom PET and Dementias

    11/18

    Case 3

    61/F

    C/o decreased

    attention and

    decreased cognition CT temporoparietal

    atrophy, moderateperiventricularischemia

  • 8/2/2019 Chuppa Rustom PET and Dementias

    12/18

    PET-CT findings, Evaluation withScenium

    Parietal and temporaldeficits

    Marked occipitalhypometabolism

    Preserved frontalmetabolism

    Lewy Body Dementia

  • 8/2/2019 Chuppa Rustom PET and Dementias

    13/18

    PET Present Status

    Adds to clinical picture improves diagnosticaccuracy

    Dementia diagnosis sensitivity with PET 91.5

    +/- 3.5%, sensitivity without PET 66 +/- 17% To differentiate AD from FTD

    Early identification of patients who will developAD and other dementias

    Sensitive to AD-like hypometabolic changes innon-dementedpersons with APOE-4 risk forAD

  • 8/2/2019 Chuppa Rustom PET and Dementias

    14/18

    PET Present Status

    Predicts cognitive decline in patients with APOE-4, normal elderly and persons with mild memoryimpairment

    Predicts progression from Mild CognitiveImpairment (MCI) to dementia

    Sensitive to preclinicalcognitive changes inpatients with high cognitive reserve

    Normal study reassures worried well Role in Age-Associated Memory Impairment

    (AAMI)

  • 8/2/2019 Chuppa Rustom PET and Dementias

    15/18

    Future Trends

    F18-FDDNP tovisualise neurofibrillarytangles and senileplaques in AD; amyloid

    labelling to followneuropathologic evolutionof AD in living subjects

    F18-MPPF selectiveprobe for serotonin 1A

    receptors as an index ofhippocampal neuronalloss early detection andmonitoring of dementias

  • 8/2/2019 Chuppa Rustom PET and Dementias

    16/18

    Future Trends

    Newer compoundslike F18-FDOPA andothers to study

    dopamine synthesis,dopamine transporterand vesiculartransporter in

    Parkinsons disease

  • 8/2/2019 Chuppa Rustom PET and Dementias

    17/18

    Future Trends

    C11-PK11195 aperipheral BZDreceptor agent

    shows increaseduptake in AD, PD,multisystem atrophy,MND may correlate

    with disease severityand mark diseaseonset

  • 8/2/2019 Chuppa Rustom PET and Dementias

    18/18

    References

    PET in the Evaluation of Alzheimers

    Disease and Related Disorders DanielSilverman

    The Dementia India Report 2010